Based on the US FDA, work is underway to quickly problem an emergency clearance for the Pfizer vaccine
© Reuters. Handout photos to prepare for the COVID-19 vaccine
(Reuters) – The US Food and Drug Administration announced on Friday that it would work swiftly towards finalizing and issuing an emergency permit Pfizer Inc (NYSE 🙂 COVID-19 vaccine.
A panel of external advisors to the FDA voted overwhelmingly on Thursday to endorse the emergency use of the vaccine and paved the way for the agency to clear the shot for a country that has lost more than 285,000 lives to COVID-19.
The agency has also notified the U.S. Centers for Disease Control and Prevention and the warp speed of the operation so they can carry out their plans for a timely distribution of the vaccine.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading loss you may incur as a result of using this information.
Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please be fully informed about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.